The relationship between Quetelet's index and subsequent risk for cancer of endocrine target organs was studied in a cohort of 47,003 women, examined for height and weight in the years 1963-65, and followed up in the Swedish Cancer Register until 1987. High Quetelet's index was associated with a decreased risk for breast cancer among women less than 55 years of age at risk, while a high Quetelet's index predicted an increased risk among older women. Among women > 55 years of age, the excess relative risk for breast cancer associated with high Quetelet's index declined significantly during the follow-up period. Cancer of the ovaries and the uterine cervix were not significantly related to Quetelet's index in any age group. In women > 55 years of age, the relative risk for cancer of the uterine corpus associated to Quetelet's index was higher than that for breast cancer, and this association persisted during the entire follow-up period of more than 20 years. In spite of the fact that endometrial cancer is less common than breast cancer, because of the stronger relation between overweight and endometrial cancer, more endometrial cancer would be attributable to obesity than breast cancer.
In correlational studies on cancer incidence in different countries, cancers of the female endocrine target organs, i.e. breast, cervix uteri, corpus uteri and ovary, have similar international distributions, which could indicate common aetiological factors (Parkin, 1989; Albanes & Taylor, 1990 ).
Overweight, often described by a high Quetelet's index (kg m-2), has been described as a risk factor for all of the above-mentioned cancer sites (Lew & Garfinkel, 1979; Garfinkel, 1986; Folsom et al., 1989; La Vecchia et al., 1991) .
Breast cancer and Quetelet's index has been extensively studied, and negative correlations among premenopausal women and positive correlations among post-menopausal women have been the dominant findings (de Waard, 1975; Willet et al., 1985; Le Marchand et al., 1988; Tornberg et al., 1988; London et al., 1989; Vatten & Kvinnsland, 1990) .
Cancer of the uterine corpus, i.e. endometrial cancer, shows a strong positive correlation with overweight among both premenopausal and post-menopausal women (La Vecchia et al., 1984 Tretli & Magnus, 1990) . Weight gain and body fat pattern also seem to play a role in endometrial carcinogenesis (Le Marchand et al., 1991) , at least among post-menopausal women. Cancer of the ovaries and cervix has also been associated with overweight (Garfinkel, 1986; Farrow et al., 1989; Slattery et al., 1989) , which however, for ovarian cancer, has not been confirmed in all studies (Szamborski et al., 1981; Shu et al., 1989) .
In the relationships between overweight and hormonedependent cancers, differences have been described for premenopausal and post-menopausal women. Thus it appears that menopausal status, i.e. levels of oestrogen and progesterone, play a role in the relationships between cancer risk and Quetelet's index (de Waard, 1975; Adami et al., 1977; La Vecchia et al., 1984; Tornberg et al., 1988; Le Marchand et al., 1988; Folsom et al., 1989; London et al., 1989; Tretli, 1989; Tretli & Magnus, 1990; Levi et al., 1992) .
In a previous study of this cohort of more than 47,000 women, we found an increased risk for breast cancer among obese post-menopausal women (Tornberg et al., 1988 The mean body mass index (BMI) was 24.9 kg m2 and the standard deviation was 3.9. The women were grouped into five categories of almost equal size (quintiles) with respect to their Quetlet's index. Owing to the lack of data on menopausal status, the cohort was also divided in groups of <55 and > 55 years of age at risk of cancer.
The risk relationships between cancers of the breast, endometrium, ovaries and uterine cervix and Quetelet's index categories were analysed using the log-linear Poisson regression model (Breslow & Day, 1987) . In the analysis, adjustments were made for age at risk (5-year groups) and period of follow-up (5-year groups).
Results
During the period of follow-up, 2,479 cancers of endocrine target organs were found in the cohort: 330 ovarian cancers,were included in the study. The total number of person-years at risk was 956,185. The number of person-years at risk for each category of Quetelet's index is shown in Table I .
The risk of breast cancer was negatively correlated with Quetelet's index among women <55 years, whereas obese women > 55 years of age had an increased risk of breast cancer (Table II) . The difference in average increase in relative risk of breast cancer (for each Quetelet's index category) between the two age groups, 1.05 vs 0.86, was also significant (P = 0.013). There were no significant risk relationships between Quetelet's index and cervical cancer or ovarian cancer. The risk for endometrial cancer increased with increasing Quetelet's index category, although the trend was significant only for women 55 years of age or older (Table II) .
The relative risk for endometrial cancer in relation to overweight, among women > 55 years of age at risk, was significantly higher (P<0.0001) than the corresponding relative risk for breast cancer.
The positive risk relationship between Quetelet's index and breast cancer among women > 55 years of age was limited to the first two periods of follow-up (Figure 1) , and the declining relative risk with follow-up time was also statistically significant (P = 0.041). The corresponding relative risk for endometrial cancer was consistent and significantly correlated to Quetelet's index during almost all periods of follow-up ( Figure 1 ).
Discussion
We found increased risks for breast cancer and endometrial cancer among obese women > 55 years of age. The findings aNumber of cases is given within parentheses.
Thus, the risk estimates are probably underestimated, though the extent of this underestimation is difficult to quantify. Both the breast and the endometrial mucosa are target organs for sex hormones, i.e. oestrogen and progesterone, and there are different mechanisms suggested for increased levels of oestrogen among obese post-menopausal women (Siiteri, 1987; Boman et al., 1990) . Obesity makes more androgen precursors available for conversion to oestrogen in peripheral tissues, and adipose tissue is the major tissue site of that conversion. Plasma levels of sex hormone-binding globulin (SHBG) are depressed in obese subjects, resulting in an increased level of free oestrogen and an increased effect on the target cells. This hypothesis does not explain the differences in relative risk between breast cancer and endometrial cancer in relation to Quetelet's index. However, the differences must be due to different effects of oestrogen in breast tissue and on the endometrial mucosa.
Breast cancer and endometrial cancer show differences in incidence rates in different age groups (National Board of Health and Welfare, 1991) . Endometrial cancer has its incidence maximum around the age of 60 and shows a slow decrease thereafter. In contrast, breast cancer incidence steadily increases with age. Endometrial cancer could be less common before menopause because of the protective effect of progesterone . After the menopause this protective effect is lost, making a carcinogenic effect of oestrogen dominant. In contrast, breast cancer is also a common disease among premenopausal women and oestrogen is believed to have a promoting effect in the breast tissue. In a large prospective study of women receiving hormone replacement therapy it was shown that the risks were increased for both endometrial cancer and breast cancer, and also that the excess relative risk was higher for endometrial cancer than for breast cancer Bergkvist et al., 1989) . One reason for relative risk of breast cancer being lower than the relative risk for endometrial cancer in relation to Quetelet's index could be that oestrogen does not affect oestrogen receptor (ER)-negative breast cancers, and the effect of overweight, i.e. increased oestrogen level, was limited to ER-positive breast cancers during the first years of follow-up. In spite of the fact that the incidence of endometrial cancer is lower than for breast cancer, a larger number of endometrial cancers, in absolute terms, would be attributable to obesity than breast cancer according to the present findings. This study confirms previously described findings of positive correlations between obesity and cancer of the breast and the endometrium among older women. However, the clear-cut effect of obesity on endometrial cancer risk, a risk that was stable for the entire follow-up period, and its lesser effect on relative breast cancer risk, suggests different aetiological mechanisms. It seems that the above-described mechanism of altered post-menopausal hormonal homeostastis due to obesity, in which additional oestrogen is produced in adipose tissue, is a major mechanism for increased risk of endometrial cancer. 
